지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2021.1
- 수록면
- 361 - 377 (17page)
이용수
초록· 키워드
오류제보하기
Intravesical bacillus Calmette–Guérin (BCG) immunotherapy has been the gold standard adjuvant treatment for intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC) after transurethral resection of bladder tumor (TURBT). BCG immunotherapy prevents disease recurrence and progression to muscle-invasive disease following TURBT. Although most patients initially respond well to intravesical BCG, considerable concern has been raised for patients with BCG failure who are refractory or recur in 6 months after their last BCG, which implies ‘BCG-unresponsiveness’. Based on current clinical guidelines, early radical cystectomy (RC) is recommended to treat BCG-unresponsive NMIBC. However, due to the high risk of morbidity and mortality of RC and patients' desire to preserve their own bladder, there is a critical unmet need for alternative conservative treatments as bladder-sparing strategies in BCG-unresponsive patients. Trials for effective bladder-sparing treatments are ongoing, and several novel agents have been recently tested in the NMIBC setting. The goal of this review is to introduce and summarize recently reported novel and emerging drugs and ongoing clinical trials for BCG-unresponsive NMIBC.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Treatment strategies for the Bacillus Calmette-Guérin–unresponsive non-muscle invasive bladder cancer
Investigative and Clinical Urology
2023 .03
-
Comparative analysis of recurrence rates between intravesical gemcitabine and bacillus Calmette–Guérin induction therapy following transurethral resection of bladder tumors in patients with intermediate- and high-risk bladder cancer: A retrospective multicenter study
Investigative and Clinical Urology
2024 .05
-
A possible protective role for Bacillus Calmette-Guérin therapy in urinary bladder cancer in the era of COVID-19: a brief report
Clinical and Experimental Vaccine Research
2021 .01
-
Efficacy of Bacillus Calmette-Guérin in Cancer Prevention and Its Putative Mechanisms
대한암예방학회지
2024 .03
-
Neoadjuvant Chemotherapy-Guided Bladder-Sparing Treatment for Muscle-Invasive Bladder Cancer: Results of a Pilot Phase II Study
Cancer Research and Treatment
2021 .10
-
Toward Better Predictions of Chemosensitivity: Comparative Study of Conventional and Simulated Chemosensitivity Tests for Bladder Cancer Cell Lines
Annals of Laboratory Medicine
2017 .07
-
External validation of European Association of Urology NMIBC risk scores to predict progression after transurethral resection of bladder tumor in Korean patients with non-muscle-invasive bladder cancer
Investigative and Clinical Urology
2022 .09
-
Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer: Abridged summary of the Cochrane Review
Investigative and Clinical Urology
2020 .01
-
Symptoms of Bacillus Calmette-Guerin Cystitis in Bladder Cancer Patients according to Tuberculosis Sequelae by Chest Radiography
Urogenital Tract Infection
2017 .01
-
Antitumor effects of intravesical treatment on bacillus calmette-guerin cell wall cytoskeleton with encapsulated liposome in orthotopic mouse model of bladder cancer
한국실험동물학회 학술발표대회 논문집
2019 .07
-
Gender-related outcomes in robot-assisted radical cystectomy: A multi-institutional study
Investigative and Clinical Urology
2022 .01
-
Active surveillance for nonmuscle invasive bladder cancer
Investigative and Clinical Urology
2016 .01
-
Genetic and Epigenetic Alterations in Bladder Cancer
International Neurourology Journal
2016 .01
-
Short-term outcomes of intravesical gemcitabine for non-muscle-invasive bladder cancer after recent approval for use in Korea
Investigative and Clinical Urology
2024 .09
-
Diabetes is an Important Risk Factor for Metastasis in Non-Muscle-Invasive Bladder Cancer
Asian Pacific journal of cancer prevention : APJCP
2016 .01
-
Seminal Vesicle Involvement by Carcinoma In Situ of the Bladder: Clonal Analysis Using Next-Generation Sequencing to Elucidate the Mechanism of Tumor Spread
Cancer Research and Treatment
2020 .01
-
Role of oral pentosan polysulfate in Bacillus Calmette?Guerin therapy in patients with non-muscle-invasive bladder cancer
Investigative and Clinical Urology
2022 .09
-
Implantable Bladder Sensors: A Methodological Review
International Neurourology Journal
2015 .01
-
Rates and Risk Factors of Bacteriuria in Patients with Bladder Cancer Who Underwent Treatment with Bacillus Calmette-Guerin
Urogenital Tract Infection
2020 .01
-
Implantable Bladder Sensors for Long-term Monitoring of Bladder Volume
International Neurourology Journal
2015 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0